A New Decision Support System for Type 1 Diabetes Management

• Main Authors: Cappon, Giacomo, Noaro, Giulia, Camerlingo, Nunzio, Cossu, Luca, Sparacino, Giovanni, Facchinetti, Andrea
• Format: Conference Proceeding
• Language: English
• Subjects: Blood Glucose; Blood Glucose Self-Monitoring; Decision support systems; Diabetes; Diabetes Mellitus, Type 1 - drug therapy; Glucose; Humans; Insulin - therapeutic use; Insulin Infusion Systems; Prototypes; Sensors; Servers
• ISSN: 2694-0604
• DOI: 10.1109/EMBC46164.2021.9629797

Type 1 diabetes (T1D) is a chronic life-threatening metabolic condition which needs to be accurately and continuously managed with care by multiple daily exogenous insulin injections, frequent blood glucose concentration monitoring, ad-hoc diet, and physical activity. In the last decades, new technologies, such as continuous glucose monitoring sensors, eased the burden for T1D patients and opened new therapy perspectives by fostering the development of decision support systems (DSS). A DSS for T1D should be able to provide patients with advice aimed at improving metabolic control and reducing the number of actions related to therapy handling. Major challenges are the vast intra-/inter-subject physiological variability and the many factors that impact glucose metabolism. The present work illustrates a new DSS for T1D management. The algorithmic core includes a module for optimal, personalized, insulin dose calculation and a module that triggers the assumption of rescue carbohydrates to avoid/mitigate impending hypoglycemic events. The algorithms are integrated within a prototype communication platform that comprises a mobile app, a real-time telemonitoring interface, and a cloud server to safely store patients' data. Tests made in silico show that the use of the new algorithms lead to metabolic control indices significantly better than those obtained by the standard care for T1D. The preliminary test of the prototype platform suggests that it is robust, performant, and well-accepted by both patients and clinicians. Future work will focus on the refinement of the communication platform and the design of a clinical trial to assess the system effectiveness in real-life conditions.Clinical Relevance- The presented DSS is a promising tool to facilitate T1D daily management and improve therapy efficacy.